Lilly breaks ground on $4.5B foundry campus in Lebanon’s LEAP District
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of discovering new medicines and getting them to patients.
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
Indiana lawmakers discovered this legislative session that performing major financial surgery on multibillion-dollar nonprofit hospital systems is a motley and entangled task.
In addition, IU LAB announced that its accelerator programs will now be called IU Health Incubator at IU LAB, thanks to a $4.5 million, three-year sponsorship deal with IU Health.
The test, one of the first of its kind, is designed to reach patients who may forgo traditional screening because of lack of access, past trauma or embarrassment.
The Carmel center, which opened Monday, has 17 infusion rooms, eight rooms for clinical visits, a procedure room and a pharmacy.
The drugmaker accuses Premier Weight Loss of risking patients’ health by selling altered, unsterile versions of its blockbuster drugs Mounjaro and Zepbound.
At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid. Indiana is not one of them.
Syra Health Corp. plans to offer stock on the over-the-counter market after the company failed to meet Nasdaq Stock Market’s price requirements for its shares.
The company said its goal is to reduce wait times for patients seeking access to specialists, creating more opportunities for early diagnosis and intervention.
Aside from building four new plants, Johnson & Johnson said that it will expand several existing sites.
“People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of management.”
Indianapolis has been awash in Big Ten logos amid the conference’s basketball tournaments. But Indy is home to another sort of Big Ten gathering—one focused on improving cancer research.
Speaking at IBJ’s Technology Power Breakfast on Monday, U.S. Sen. Todd Young of Indiana also discussed the challenge of striking a balance between encouraging innovation in artificial intelligence and developing necessary guardrails.
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to connect directly with consumers on the platform since.
The pre-clinical West Lafayette-based medical device startup is working to develop a new “microstructred” catheter to remove blood clots that cause strokes.
For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks. And 2025 holds more challenges but also an opportunity for a rebound.
The foundry will give the pharmaceutical maker the ability to research new ways of producing medicines.
President Donald Trump has instructed his administration to scrutinize the “threat” to children posed by antidepressants, stimulants and other common psychiatric drugs.